Molecular Vision: Rauf, Mol Vis 2020; 26:14-25. Table 1

Table 1. Clinical characteristics of affected individuals of PKGL076, PKGL015 and PKGL042.

Family ID	Individual ID	Age at Enrollment	Max. IOP (OD/OS)	CD Ratio (OD/OS)	VA(OD/OS)	Corneal Diameter (B/L)	Other Clinical findings
PKGL076	7	3 Years	36/26	NV/NV	PL/PL	Increased	B/L Bu, CE, CH
PKGL076	8	6.5 Years	28/24	NV/NV	PL/CF	>13mm	B/L Mc, B/L NY.
PKGL076	9	16 Years	NA	0.6/0.4	NPL/PL	Increased	B/L Bu, B/L MF
PKGL015	12	6 Years	40/21	1.0/NV	CF/NPL	NA	Bu, CE
PKGL015	15	5 Years	NV/36	NV/0.9	CF	NA	Only Left Eye, FT
PKGL015	17	8 Years	NA	1.0/NV	CF	NA	Only Right eye, Ap, PI
PKGL042	9	16 years	36/NV	1.0/NV	HM/HM	Increased	Bu, CO
PKGL042	10	12 years	NA	NV/NV	PL/PL	Increased	B/L Bu, B/L CO
PKGL042	11	14 years	24/22	0.7/0.4	PL/HM	13/14mm	B/L Bu, CO, B/L NY.

IOP: intraocular pressure; OD: oculus dexter; OS: oculus sinister; CD Ratio: cup to disc ratio; VA: visual acuity; NV: no view; PL: light perception; NPL: no light perception; HM: hand movement; CF: counting fingers; B/L: bilateral; Bu: buphthalmos; CH: corneal haze; CE: corneal edema; NY: nystagmus; Mc: megalocornea; MF: myopic fundus; Ap: Aphakia; PI: peripheral Iridectomy; FT: Failed trabeculectomy, CO: corneal opacity.